| |||||||||||||||||||||||||||||||||||
Parent-child relations graph | Deprecated MNXref IDs graph |
Identifier | Description |
---|---|
CHEBI:42068 chebi:42068 | idarubicin (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside 4-Demethoxydaunomycin 4-Demethoxydaunorubicin 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)- |
CHEBI:94972 chebi:94972 | (7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione |
kegg.drug:D08062 keggD:D08062 | Idarubicin (INN) Zavedos (TN) |
hmdb:HMDB0015308 | Idarubicin (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione 4 Demethoxydaunorubicin 4 Desmethoxydaunorubicin 4-Demethoxydaunomycin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin Hydrochloride, idarubicin IMI 30 IMI-30 IMI30 Idarubicin hydrochloride Zavedos idarubicin |
metacyc.compound:CPD-15814 metacycM:CPD-15814 seed.compound:cpd35622 seedM:cpd35622 | idarubicin |
hmdb:HMDB15308 chebi:35758 chebi:42066 keggD:M_D08062 seedM:M_cpd35622 | secondary/obsolete/fantasy identifier |